Literature DB >> 28146373

Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.

Haitao Feng1, Jin-Jian Lu1, Yitao Wang1, Lixia Pei2, Xiuping Chen1.   

Abstract

Epithelial-mesenchymal transition (EMT), the transdifferentiation of epithelial cells into mesenchymal cells, has been implicated in the metastasis and provides novel strategies for cancer therapy. Osthole (OST), a dominant active constituent of Chinese herb Cnidium monnieri, has been reported to inhibit cancer metastasis while the mechanisms remains unclear. Here, we studied the inhibitory effect and mechanisms of OST on TGF-β1-induced EMT in A549 cells. Cells were treated with TGF-β1 in the absence and presence of OST. The morphological alterations were observed with a microscopy. The protein and mRNA expressions were determined by Western blotting and real-time PCR. The protein localization was detected with immunofluorescence. The adhesion, migration, and invasion were determined by Matrigel, wound-healing, and Transwell assays. TGF-β1 treatment induced spindle-shaped alterations of cells, upregulation of N-cadherin, Vimentin, NF-κB p65, and downregulation of E-cadherin. Dysregulated membrane expression and mRNA expression of E-cadherin and N-cadherin were observed after TGF-β1 treatment. TGF-β1 increased abilities of migration and invasion and triggered the nuclear translocation of NF-κB p65. These alterations were dramatically inhibited by OST. Furthermore, PDTC, a NF-κB inhibitor, showed similar effects. In addition, TGF-β1-induced expression of Snail was significantly inhibited by OST and silenced Snail partially reversed TGF-β1-induced EMT biomarkers without affecting NF-κB p-65. In conclusion, OST inhibited TGF-β1-induced EMT, adhesion, migration, and invasion through inactivation of NF-κB-Snail pathways in A549 cells. This study provides novel molecular mechanisms for the anti-metastatic effect of OST.

Entities:  

Keywords:  EMT; NF-κB; Osthole; Snail; TGF-β1

Mesh:

Substances:

Year:  2017        PMID: 28146373      PMCID: PMC5810511          DOI: 10.1080/19336918.2016.1259058

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  42 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.

Authors:  Chenfang Dong; Yadi Wu; Jun Yao; Yifan Wang; Yinhua Yu; Piotr G Rychahou; B Mark Evers; Binhua P Zhou
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

3.  Epithelial-mesenchymal transition: Untangling EMT's functions.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2015-11-27       Impact factor: 60.716

Review 4.  Crossing the endothelial barrier during metastasis.

Authors:  Nicolas Reymond; Bárbara Borda d'Água; Anne J Ridley
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

5.  Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells.

Authors:  Chao-Ming Hung; Daih-Huang Kuo; Chun-Hung Chou; Yen-Chao Su; Chi-Tang Ho; Tzong-Der Way
Journal:  J Agric Food Chem       Date:  2011-08-08       Impact factor: 5.279

6.  Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways.

Authors:  Lee A Borthwick; Aaron Gardner; Anthony De Soyza; Derek A Mann; Andrew J Fisher
Journal:  Cancer Microenviron       Date:  2011-07-27

7.  Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression.

Authors:  Melody L Stallings-Mann; Jens Waldmann; Ying Zhang; Erin Miller; Mona L Gauthier; Daniel W Visscher; Gregory P Downey; Evette S Radisky; Alan P Fields; Derek C Radisky
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

8.  Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma.

Authors:  Lu Wang; Lei Yang; Ying Lu; Yingzhun Chen; Tianhua Liu; Yanli Peng; Yuhong Zhou; Yang Cao; Zhenggang Bi; Tianyi Liu; Zhenhong Liu; Hongli Shan
Journal:  Cell Physiol Biochem       Date:  2016-05-17

Review 9.  Signaling mechanisms of the epithelial-mesenchymal transition.

Authors:  David M Gonzalez; Damian Medici
Journal:  Sci Signal       Date:  2014-09-23       Impact factor: 8.192

10.  Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression.

Authors:  Cheng-Fang Tsai; Wei-Lan Yeh; Jia-Hong Chen; Chingju Lin; Shiang-Suo Huang; Dah-Yuu Lu
Journal:  Int J Mol Sci       Date:  2014-03-04       Impact factor: 5.923

View more
  22 in total

1.  Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells.

Authors:  Xiaojiang Li; Shaojun Ma; Peiying Yang; Binxu Sun; Ying Zhang; Yuehong Sun; Meimei Hao; Ruiyu Mou; Yingjie Jia
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

2.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

3.  CMAHP promotes metastasis by reducing ubiquitination of Snail and inducing angiogenesis via GM-CSF overexpression in gastric cancer.

Authors:  Hsiang-Wei Huang; Ching-Ying Chen; Ya-Hui Huang; Chau-Ting Yeh; Chia-Siu Wang; Cheng-Chih Chang; Kwang-Huei Lin
Journal:  Oncogene       Date:  2021-10-29       Impact factor: 9.867

Review 4.  Potential Anticancer Properties of Osthol: A Comprehensive Mechanistic Review.

Authors:  Yalda Shokoohinia; Fataneh Jafari; Zeynab Mohammadi; Leili Bazvandi; Leila Hosseinzadeh; Nicholas Chow; Piyali Bhattacharyya; Mohammad Hosein Farzaei; Ammad Ahmad Farooqi; Seyed Mohammad Nabavi; Mükerrem Betül Yerer; Anupam Bishayee
Journal:  Nutrients       Date:  2018-01-03       Impact factor: 5.717

5.  Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.

Authors:  Zhiliang Lu; Yuan Li; Jingnan Wang; Yun Che; Shouguo Sun; Jianbing Huang; Zhaoli Chen; Jie He
Journal:  J Exp Clin Cancer Res       Date:  2017-04-17

6.  Osthole inhibits gastric cancer cell proliferation through regulation of PI3K/AKT.

Authors:  Xiaojun Xu; Xiaoyuan Liu; Yan Zhang
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

7.  Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression.

Authors:  Wu Zhou; Xing Chen; Qinghua Hu; Xuliang Chen; Yingji Chen; Lingjin Huang
Journal:  BMC Cancer       Date:  2018-05-22       Impact factor: 4.430

8.  Alginate Oligosaccharide DP5 Exhibits Antitumor Effects in Osteosarcoma Patients following Surgery.

Authors:  Jiayu Chen; Yu Hu; Lirong Zhang; Yingjian Wang; Shichao Wang; Yanzi Zhang; Haiyan Guo; Degang Ji; Yingtao Wang
Journal:  Front Pharmacol       Date:  2017-09-12       Impact factor: 5.810

9.  Osthole Ameliorates Renal Fibrosis in Mice by Suppressing Fibroblast Activation and Epithelial-Mesenchymal Transition.

Authors:  Suping Zhang; Qian Huang; Xiaoxia Cai; Shan Jiang; Nan Xu; Qin Zhou; Xiaoyun Cao; Michael Hultström; Jiong Tian; En Yin Lai
Journal:  Front Physiol       Date:  2018-11-21       Impact factor: 4.566

10.  Telomerase reverse transcriptase mediates EMT through NF-κB signaling in tongue squamous cell carcinoma.

Authors:  Yan Wu; Chunxiang Bian; Chunlin Zhen; Liu Liu; Zhenghong Lin; Muhammad Farrukh Nisar; Mei Wang; Jörg W Bartsch; Enyi Huang; Ping Ji; Li Yang; Yanhong Yu; Junfeng Yang; Xuemei Jiang; Julia Li Zhong
Journal:  Oncotarget       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.